Feasibility of Early Gabapentin as an Intervention for Neurorecovery
About this trial
This is a trial enrolling individuals with recent (less than five days) traumatic spinal cord injuries to test the feasibility of using a drug on recovery. The drug, Gabapentin, is commonly used in spinal cord injury to manage neuropathic pain. Different doses of Gabapentin will be administered for 90 days. If included, participants will receive either a low dose of Gabapentin, a high dose of Gabapentin, or a placebo for comparison. Final testing will be performed after 6 months.
Included participants
Traumatic
What’s involved
Type
Details
- Oral intake of two capsules, three times a day, for 90 days
Potential benefits
Main benefits
General health
Additional benefits
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life supports SCITrialsFinder
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more- Trial recruitment status
- Recruiting
- Trial start date
- 14 Mar 2022
- Organisation
- MetroHealth Medical Center
- Trial recruitment status
- Recruiting
- Trial start date
- 14 Mar 2022
- Organisation
- MetroHealth Medical Center
About this trial
Included participants
What’s involved
Potential benefits
Wings for Life supports SCITrialsFinder
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more